Growth Metrics

Catalyst Pharmaceuticals (CPRX) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -14.40%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -9.89%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -0.31%
10 Catalyst Pharmaceuticals 3.82 Bn 3.07 Bn 134.92 Mn -8.20%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -8.20%
Dec 31, 2025 6.98%
Sep 30, 2025 6.88%
Jun 30, 2025 7.81%
Mar 31, 2025 10.23%
Dec 31, 2024 12.18%
Sep 30, 2024 13.21%
Jun 30, 2024 10.31%
Mar 31, 2024 11.48%
Dec 31, 2023 109.48%
Sep 30, 2023 99.61%
Jun 30, 2023 92.93%
Mar 31, 2023 86.87%
Dec 31, 2022 59.06%
Sep 30, 2022 84.22%
Jun 30, 2022 83.83%
Mar 31, 2022 87.50%
Dec 31, 2021 57.51%
Sep 30, 2021 67.85%
Jun 30, 2021 69.67%
Mar 31, 2021 72.67%
Dec 31, 2020 -12.10%
Sep 30, 2020 -10.13%
Jun 30, 2020 -8.45%
Mar 31, 2020 -5.21%
Dec 31, 2019 -4.84%
Sep 30, 2019 -17.26%
Jun 30, 2019 -17.04%
Mar 31, 2019 -7.68%
Dec 31, 2018 8.61%
Sep 30, 2018 0.58%
Jun 30, 2018 43.53%
Mar 31, 2018 37.11%
Dec 31, 2017 38.93%
Sep 30, 2017 42.31%
Jun 30, 2017 49.45%
Mar 31, 2017 63.77%
Dec 31, 2016 81.82%
Sep 30, 2016 75.17%
Jun 30, 2016 70.63%
Mar 31, 2016 45.63%
Dec 31, 2015 52.81%
Sep 30, 2015 163.26%
Jun 30, 2015 67.14%
Mar 31, 2015 70.45%
Dec 31, 2014 80.26%
Sep 30, 2014 57.39%
Jun 30, 2014 36.46%
Dec 31, 2013 -3.76%